# Deep Track Capital, LP: Form 13F holdings

An institutional investment manager in GREENWICH, CT. SEC CIK 1856083.

- Quarter ended: 2026-06-30
- Filed: 2026-08-14
- Reported value: $6.87bn
- Positions: 67 (67 lines in the filing's table; lines for the same security and option type are added together here)
- Compared with: the 13F for the quarter ended 2026-03-31
- Filing: https://www.sec.gov/Archives/edgar/data/1856083/000185608326000004/

## Holdings

As filed, largest first. Reported value is what the manager stated at the quarter end (Jun 30, 2026), in US dollars; it is filing data, not a price. Weight is the share of the total reported value.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [GUARDANT HEALTH INC (GH)](/companies/gh.md) | COM | $509.1m | 7.4% | 3,393,312 |  | Added +55,071 |
| [IMMUNOVANT INC (IMVT)](/companies/imvt.md) | COM | $359.9m | 5.2% | 9,341,151 |  | Reduced −2,185,820 |
| [STRUCTURE THERAPEUTICS INC (GPCR)](/companies/gpcr.md) | SPONSORED ADS | $254.4m | 3.7% | 4,740,072 |  | Added +460,224 |
| [VAXCYTE INC (PCVX)](/companies/pcvx.md) | COM | $250.0m | 3.6% | 4,300,000 |  | Unchanged |
| [ALNYLAM PHARMACEUTICALS INC (ALNY)](/companies/alny.md) | COM | $248.3m | 3.6% | 825,000 |  | New +825,000 |
| [VERADERMICS INC (MANE)](/companies/mane.md) | COMMON STOCK | $245.9m | 3.6% | 2,000,000 |  | Added +1,500,000 |
| [TARSUS PHARMACEUTICALS INC (TARS)](/companies/tars.md) | COM | $230.8m | 3.4% | 3,666,768 |  | Added +66,768 |
| NUVALENT INC | COM | $220.2m | 3.2% | 1,783,322 |  | Added +406,998 |
| ALKERMES PLC | SHS | $209.6m | 3.1% | 4,000,000 |  | Added +409,677 |
| [OCULAR THERAPEUTIX INC (OCUL)](/companies/ocul.md) | COM | $193.3m | 2.8% | 19,686,282 |  | Unchanged |
| [BIOMARIN PHARMACEUTICAL INC (BMRN)](/companies/bmrn.md) | COM | $189.3m | 2.8% | 3,307,481 |  | Added +2,157,481 |
| [NURIX THERAPEUTICS INC (NRIX)](/companies/nrix.md) | COM | $187.7m | 2.7% | 7,736,455 |  | Added +1,391,211 |
| [ORUKA THERAPEUTICS INC (ORKA)](/companies/orka.md) | COM | $183.3m | 2.7% | 1,926,000 |  | Reduced −108,203 |
| [ALUMIS INC (ALMS)](/companies/alms.md) | COM | $178.6m | 2.6% | 6,348,558 |  | Reduced −424,037 |
| [IONIS PHARMACEUTICALS INC (IONS)](/companies/ions.md) | COM | $174.4m | 2.5% | 2,200,000 |  | Added +250,000 |
| [COMPASS PATHWAYS PLC (CMPS)](/companies/cmps.md) | SPONSORED ADS | $172.1m | 2.5% | 12,161,496 |  | Unchanged |
| [VERA THERAPEUTICS INC (VERA)](/companies/vera.md) | CL A | $171.6m | 2.5% | 4,000,000 |  | Reduced −106,067 |
| [AXSOME THERAPEUTICS INC. (AXSM)](/companies/axsm.md) | COM | $171.3m | 2.5% | 700,000 |  | Reduced −400,000 |
| [GENMAB A/S (GMAB)](/companies/gmab.md) | SPONSORED ADS | $155.2m | 2.3% | 5,650,000 |  | Added +1,986,750 |
| [MOONLAKE IMMUNOTHERAPEUTICS (MLTX)](/companies/mltx.md) | CLASS A ORD | $136.3m | 2.0% | 6,999,025 |  | Added +590,162 |
| [HEMAB THERAPEUTICS HLDGS INC (COAG)](/companies/coag.md) | COM SHS | $132.3m | 1.9% | 3,602,093 |  | New +3,602,093 |
| [TANGO THERAPEUTICS INC (TNGX)](/companies/tngx.md) | COM | $131.3m | 1.9% | 4,200,000 |  | Added +1,450,000 |
| [DEFINIUM THERAPEUTICS INC (DFTX)](/companies/dftx.md) | COM SHS | $129.4m | 1.9% | 2,750,000 |  | Reduced −250,000 |
| [GRAIL INC (GRAL)](/companies/gral.md) | COM | $125.3m | 1.8% | 1,834,944 |  | Added +112,147 |
| [BICARA THERAPEUTICS INC (BCAX)](/companies/bcax.md) | COM | $121.7m | 1.8% | 4,100,000 |  | Added +37,500 |
| [MAZE THERAPEUTICS INC (MAZE)](/companies/maze.md) | COM | $111.4m | 1.6% | 3,732,569 |  | Added +255,007 |
| [CELLDEX THERAPEUTICS INC NEW (CLDX)](/companies/cldx.md) | COM NEW | $109.4m | 1.6% | 2,939,151 |  | Added +1,655,172 |
| [LB PHARMACEUTICALS INC (LBRX)](/companies/lbrx.md) | COM SHS | $108.8m | 1.6% | 3,352,804 |  | Unchanged |
| [MBX BIOSCIENCES INC (MBX)](/companies/mbx.md) | COM | $95.6m | 1.4% | 1,732,569 |  | Reduced −1,025,000 |
| GH RESEARCH PLC | ORDINARY SHARES | $89.6m | 1.3% | 3,333,334 |  | New +3,333,334 |
| [GENMAB A/S (GMAB)](/companies/gmab.md) | SPONSORED ADS | $82.4m | 1.2% | 3,000,000 | Call | New +3,000,000 |
| [COGENT BIOSCIENCES INC (COGT)](/companies/cogt.md) | COM | $77.4m | 1.1% | 2,000,000 |  | Added +1,000,000 |
| ATAIBECKLEY INC | COM SHS | $76.0m | 1.1% | 14,417,442 |  | Added +2,417,442 |
| [UNITED THERAPEUTICS CORP DEL (UTHR)](/companies/uthr.md) | COM | $67.0m | 1.0% | 123,616 |  | New +123,616 |
| [AVALO THERAPEUTICS INC (AVTX)](/companies/avtx.md) | COM NEW | $66.7m | 1.0% | 3,610,000 |  | New +3,610,000 |
| [VIRIDIAN THERAPEUTICS INC (VRDN)](/companies/vrdn.md) | COM | $66.0m | 1.0% | 3,592,740 |  | Added +2,198,796 |
| [CYTOKINETICS INC (CYTK)](/companies/cytk.md) | COM NEW | $59.6m | 0.9% | 700,000 |  | Reduced −674,320 |
| [ALTIMMUNE INC (ALT)](/companies/alt.md) | COM NEW | $58.5m | 0.9% | 19,250,000 |  | New +19,250,000 |
| [PERSONALIS INC (PSNL)](/companies/psnl.md) | COM | $53.6m | 0.8% | 4,000,000 |  | Added +1,000,000 |
| [ACLARIS THERAPEUTICS INC (ACRS)](/companies/acrs.md) | COM | $49.4m | 0.7% | 9,345,000 |  | Unchanged |
| [CORMEDIX INC (CRMD)](/companies/crmd.md) | COM | $49.3m | 0.7% | 6,274,076 |  | Unchanged |
| [GENEDX HOLDINGS CORP (WGS)](/companies/wgs.md) | COM CL A | $48.1m | 0.7% | 700,000 |  | New +700,000 |
| [HARROW INC (HROW)](/companies/hrow.md) | COM | $41.2m | 0.6% | 969,000 |  | New +969,000 |
| [CORVUS PHARMACEUTICALS INC (CRVS)](/companies/crvs.md) | COM | $37.2m | 0.5% | 2,491,939 |  | Added +400 |
| [SOLID BIOSCIENCES INC (SLDB)](/companies/sldb.md) | COM NEW | $35.6m | 0.5% | 3,565,062 |  | Unchanged |
| [BEAM THERAPEUTICS INC (BEAM)](/companies/beam.md) | COM | $34.3m | 0.5% | 1,000,000 |  | Added +179,235 |
| [DYNE THERAPEUTICS INC (DYN)](/companies/dyn.md) | COM | $33.3m | 0.5% | 1,500,000 |  | Reduced −500,000 |
| [IMMIX BIOPHARMA INC (IMMX)](/companies/immx.md) | COM | $28.6m | 0.4% | 2,775,000 |  | New +2,775,000 |
| [X4 PHARMACEUTICALS INC (XFOR)](/companies/xfor.md) | COM NEW | $27.5m | 0.4% | 5,878,757 |  | Reduced −460,778 |
| [SHATTUCK LABS INC (STTK)](/companies/sttk.md) | COM | $25.7m | 0.4% | 3,706,734 |  | New +3,706,734 |
| [MANNKIND CORP (MNKD)](/companies/mnkd.md) | COM NEW | $25.6m | 0.4% | 6,000,000 |  | New +6,000,000 |
| [CENTURY THERAPEUTICS INC (IPSC)](/companies/ipsc.md) | COM | $23.2m | 0.3% | 9,462,645 |  | Reduced −25,100 |
| [GENERATE BIOMEDICINES INC (GENB)](/companies/genb.md) | COM SHS | $22.5m | 0.3% | 1,333,815 |  | New +1,333,815 |
| [VERASTEM INC (VSTM)](/companies/vstm.md) | COM NEW | $21.9m | 0.3% | 5,740,850 |  | Unchanged |
| [KURA ONCOLOGY INC (KURA)](/companies/kura.md) | COM | $21.7m | 0.3% | 1,978,565 |  | Reduced −664,977 |
| [ENANTA PHARMACEUTICALS INC (ENTA)](/companies/enta.md) | COM | $21.1m | 0.3% | 1,444,167 |  | Reduced −512,700 |
| [NEKTAR THERAPEUTICS (NKTR)](/companies/nktr.md) | COM NEW | $20.9m | 0.3% | 300,000 |  | New +300,000 |
| [OLEMA PHARMACEUTICALS INC (OLMA)](/companies/olma.md) | COM | $18.8m | 0.3% | 1,500,000 |  | New +1,500,000 |
| [KAILERA THERAPEUTICS INC (KLRA)](/companies/klra.md) | COMMON STOCK | $15.4m | 0.2% | 700,000 |  | New +700,000 |
| [KARDIGAN INC (KARD)](/companies/kard.md) | COM | $14.3m | 0.2% | 600,000 |  | New +600,000 |
| [ENLIVEN THERAPEUTICS INC (ELVN)](/companies/elvn.md) | COM | $11.4m | 0.2% | 225,000 |  | New +225,000 |
| [PROMIS NEUROSCIENCES INC (PMN)](/companies/pmn.md) | COM SHS | $11.0m | 0.2% | 835,655 |  | Unchanged |
| [IMMUNOCORE HLDGS PLC (IMCR)](/companies/imcr.md) | ADS | $9.9m | 0.1% | 311,218 |  | Reduced −1,620,666 |
| [XENCOR INC (XNCR)](/companies/xncr.md) | COM | $9.6m | 0.1% | 593,551 |  | New +593,551 |
| [CONTEXT THERAPEUTICS INC (CNTX)](/companies/cntx.md) | COM | $4.1m | <0.1% | 7,419,355 |  | Unchanged |
| [INVENTIVA SA (IVA)](/companies/iva.md) | ADS | $3.0m | <0.1% | 800,000 |  | Reduced −422,453 |
| [ALIGOS THERAPEUTICS INC (ALGS)](/companies/algs.md) | COM NEW | $2.6m | <0.1% | 444,110 |  | Unchanged |

## Sold out

Held at the end of the quarter before and not reported this quarter.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [ANI PHARMACEUTICALS INC (ANIP)](/companies/anip.md) | COM | $0 | 0.0% | 0 |  | Sold out −600,000 |
| APELLIS PHARMACEUTICALS INC | COM | $0 | 0.0% | 0 |  | Sold out −4,532,374 |
| APOGEE THERAPEUTICS INC | COM | $0 | 0.0% | 0 |  | Sold out −285,000 |
| [BILLIONTOONE INC (BLLN)](/companies/blln.md) | CL A | $0 | 0.0% | 0 |  | Sold out −50,000 |
| [BRIDGEBIO PHARMA INC (BBIO)](/companies/bbio.md) | COM | $0 | 0.0% | 0 |  | Sold out −841,445 |
| CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | $0 | 0.0% | 0 |  | Sold out −3,158,041 |
| CRESCENT BIOPHARMA INC. | COM | $0 | 0.0% | 0 |  | Sold out −453,686 |
| CYBIN INC | COM NEW | $0 | 0.0% | 0 |  | Sold out −1,313,137 |
| ENGENE HOLDINGS INC | COM | $0 | 0.0% | 0 |  | Sold out −4,377,572 |
| [GERON CORP (GERN)](/companies/gern.md) | COM | $0 | 0.0% | 0 |  | Sold out −31,720,278 |
| [JANUX THERAPEUTICS INC (JANX)](/companies/janx.md) | COM | $0 | 0.0% | 0 |  | Sold out −1,187,290 |
| [LARIMAR THERAPEUTICS INC (LRMR)](/companies/lrmr.md) | COM | $0 | 0.0% | 0 |  | Sold out −1,500,000 |
| SOLENO THERAPEUTICS INC | COM | $0 | 0.0% | 0 |  | Sold out −1,078,710 |
| SPDR SERIES TRUST | STATE STREET SPD | $0 | 0.0% | 0 | Put | Sold out −10,000,000 |
| TERNS PHARMACEUTICALS INC | COM | $0 | 0.0% | 0 |  | Sold out −1,073,877 |

Source: SEC EDGAR, Form 13F-HR, accession 0001856083-26-000004. Last ingested by Listed: Oct 22, 2026, 05:26 ET. No prices; not investment advice.